Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors.
D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism*; D003994:Bucladesine / Q000494:pharmacology; D003094:Collagen / Q000037:antagonists & inhibitors*; D003571:Cytochalasin B / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D013748:Tetracaine / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D001798:Blood Proteins; D011458:Prostaglandins E; D013748:Tetracaine; D003571:Cytochalasin B; D003994:Bucladesine; D003094:Collagen; D014700:Verapamil; D005033:Ethylmaleimide; D007213:Indomethacin